-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOCRYST PHARMACEUTICALS INC - SEEKS TO BLOCK FDA APPROVAL OF GENERIC ORLADEYO UNTIL PATENT EXPIRATION

Reuters·03/11/2025 10:28:53

Please log in to view news